Search hospitals
>
Missouri
>
Kansas City
University of Kansas Cancer Center
Claim this profile
Kansas City, Missouri 64131
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Prostate Cancer
Conducts research for Pancreatic Cancer
435 reported clinical trials
47 medical researchers
Summary
University of Kansas Cancer Center is a medical facility located in Kansas City, Missouri. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Prostate Cancer, Pancreatic Cancer and other specialties. University of Kansas Cancer Center is involved with conducting 435 clinical trials across 576 conditions. There are 47 research doctors associated with this hospital, such as Jun Zhang, Chao H. Huang, Anwaar Saeed, and Gary C. Doolittle.
Area of expertise
Breast Cancer
University of Kansas Cancer Center has run 56 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
University of Kansas Cancer Center has run 54 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Jun Zhang
Houston Methodist Hospital
6 years of reported clinical research
Chao H. Huang
University of Kansas Health System Saint Francis Campus
6 years of reported clinical research
Anwaar Saeed
University of Kansas Cancer Center
4 years of reported clinical research
Gary C. Doolittle
Salina Regional Health Center
3 years of reported clinical research
Clinical Trials running at University of Kansas Cancer Center
Lung Cancer
Breast Cancer
Prostate Cancer
Skin Cancer
Breast cancer
Colorectal Cancer
Cancer
Pancreatic Cancer
Bladder Cancer
Colon Cancer
Proton Craniospinal Radiation
for Cancer in the Brain and Spinal Cord
This phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell lung cancer that has spread from where it first started to the cerebrospinal fluid filled space that surrounds the brain and spinal cord (leptomeningeal metastasis). Patients with leptomeningeal metastasis (LM) may develop multiple areas of nervous system (neurologic) impairment that can be life-threatening. Radiation therapy (RT) effectively relieves local symptoms due to LM. RT uses high energy radiography (x-rays), particles, or radioactive seeds to kill cancer cells and shrink tumors. IFRT is commonly used to treat symptoms of LM. IFRT is radiation treatment that uses x-rays to treat specific areas of LM and to relieve and/or prevent symptoms. pCSI uses protons that can be directed with more accuracy than x-rays which allows treatment of the entire central nervous system space containing the cerebrospinal fluid (CSF), brain, and spinal cord. The pCSI treatment could delay the worsening of LM. Giving pCSI may be better than IFRT in treating LM in patients with breast or non-small cell lung cancer.
Recruiting
2 awards
Phase 3
3 criteria
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting
2 awards
Phase 3
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting
2 awards
Phase 3
12 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Kansas Cancer Center?
University of Kansas Cancer Center is a medical facility located in Kansas City, Missouri. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Prostate Cancer, Pancreatic Cancer and other specialties. University of Kansas Cancer Center is involved with conducting 435 clinical trials across 576 conditions. There are 47 research doctors associated with this hospital, such as Jun Zhang, Chao H. Huang, Anwaar Saeed, and Gary C. Doolittle.
Where is University of Kansas Cancer Center located?
The University of Kansas Cancer Center offers comprehensive medical oncology services at its facility located at 12200 West 110th Street, Overland Park, KS 66210. For inquiries or to schedule an appointment, please call 913-588-1227.
Who should I call to ask about financial aid or insurance network?
The University of Kansas Cancer Center offers comprehensive support services for cancer patients, including emotional, nutritional, financial, and genetic counseling, personal appearance services, and rehabilitation. Patients eligible for financial assistance, with a gross family income between 0% to 300% of the federal poverty guidelines, can apply through the University of Kansas Health System. For more details or to make an appointment, contact 913-588-1227 or toll-free at 844-323-1227.
What insurance does University of Kansas Cancer Center accept?
The University of Kansas Cancer Center accepts a wide range of insurance plans, including those through the University of Kansas Medical Center for its employees, covering medical, dental, vision, disability, long-term care, life insurance, and wellness programs. Additionally, it accepts various plans on the open marketplace, including Aetna CareLink, BCBS Kansas, Sunflower or Home State/Ambetter, Oscar, and Blue Cross Blue Shield of Kansas City/Blue Select. It's important to verify with your physician that they participate with your insurance plan or network before seeking services.
What awards or recognition has University of Kansas Cancer Center received?
The University of Kansas Cancer Center, located in Kansas City, Missouri, is recognized as a Comprehensive cancer center by the National Cancer Institute (NCI), a prestigious status shared with only 53 centers nationwide. This distinction is accompanied by a five-year, $13.8 million grant aimed at bolstering the center's research efforts. In partnership with the Stowers Institute for Medical Research and Children's Mercy Kansas City, the center enhances its research capabilities and extends its services to high-risk and underserved communities.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.